07.05.2012
MagForce to Present at Entry & General Standard Conference 2012 in Frankfurt
Berlin, Germany, May 07, 2012 – MagForce AG (Frankfurt, XETRA: MF6), a leading medical technology company in the field of nanomedicine for oncology, announced today that Dr Andreas Jordan, Executive Board, will deliver a presentation on the Company at the Entry & General Standard Conference ...
03.05.2012
MagForce AG hires Christian von Volkmann as Head of Finance
von Volkmann leads Financial Department with immediate effectMagforce’s Financial Department will again be headed up by a competent leaderBerlin, Germany, May 3, 2012 – MagForce AG (Frankfurt, XETRA: MF6), a leading medical technology company in the field of nanomedicine in oncology, announced ...
26.03.2012
MagForce AG Announces Company Restructuring and Revised Corporate Strategy for 2012
Greater emphasis on clinical development to provide key physicians with access to NanoTherm therapyStart of post marketing glioblastoma study Q3 2012 to support expanded market acceptance with leading medical expertsEnhanced activities for international partnerships and initiation of discussions ...
29.02.2012
MagForce AG Successfully Completes Capital Increase
Announcement in accordance with section 17 para. 2 of the General Terms and Conditions of Deutsche Börse AG for the Regulated Unofficial Market on the Frankfurt Stock ExchangeBerlin, February 29, 2012 - MagForce AG (Frankfurt, XETRA: MF6), a leading medical technology company focusing on ...
01.02.2012
MagForce AG Announces Capital Increase from Authorized Capital
· Proceeds from the capital increase will be used for the commercialization of the NanoTherm® technology and further clinical development along with the expansion of commercial and strategic partnerships Berlin, February 1, 2012- The Management Board of ...
14.12.2011
MagForce Signs Letter of Intent with Leading Russian Medical Product Distribution Company Delrus
Plans outlined for NanoTherm® therapy market entry in Russia Financial and professional support for approval in RussiaFirst step for internationalization of NanoTherm® therapy Berlin, December 14, 2011 - MagForce AG (XETRA:MF6), a leading medical technology company focusing on ...
22.11.2011
MagForce AG Announces Initiation of Research Coverage by Merchant Securities Limited
Berlin, November 22, 2011 - MagForce AG (FSE:MF6), a leading medical technology company focusing on nanomedicine in oncology, announced today that Merchant Securities Limited has initiated research coverage on the company and published its first report today. The report is available upon ...
